术前增量乳腺MRI发现的准确性——与瑞典随机多中心POMB试验组织病理学的一致性
本研究基于瑞典随机前瞻性多中心POMB试验,纳入210例56岁以下乳腺癌患者,评估术前乳腺MRI相对于常规乳腺影像的增量发现与组织病理学的一致性。78例患者共99个增量发现纳入分析,总体阳性预测值为74%(95%CI 60-84%),在MRI相关治疗计划改变的患者中为83%(95%CI 68-92%),在无改变的患者中为27%(95%CI 14-44%),促使保乳转全乳切除的增量发现阳性预测值为91%(95%CI 70-98%),全组经验AUC为85%(95%CI 78-91%)。结论认为术前乳腺MRI与常规影像联合评估可提供高度准确的增量信息。
要点
- 增量发现的阳性预测值在治疗计划改变组为83%,无改变组仅27%。
- 促使保乳转全乳切除的增量发现阳性预测值达91%(95%CI 70-98%)。
- 全组基于BI-RADS评级的增量发现经验AUC为85%(95%CI 78-91%)。
核心结论
- 术前乳腺MRI与常规乳腺影像联合评估可在术前提供高度准确的增量信息。
研究设计与样本
- 基于瑞典随机、前瞻性、多中心POMB试验,210例56岁以下乳腺癌患者在两所瑞典乳腺中心接受术前乳腺MRI,以组织病理学为参考标准。
诊断标准与关键数值
- 增量发现总体阳性预测值为74%(95%CI 60-84%);治疗计划改变组为83%(95%CI 68-92%),无改变组为27%(95%CI 14-44%);保乳转全乳切除组为91%(95%CI 70-98%);全组经验AUC为85%(95%CI 78-91%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The Pre-Operative MRI of the Breast (POMB) trial was a randomized, prospective, multicenter trial evaluating the impact of pre-operative breast MRI on treatment regimens and short-term surgical outcomes in women up to 56 years of age with breast cancer. The purpose of this study was to evaluate the performance of pre-operative breast MRI in the POMB trial with respect to incremental MRI findings - over conventional breast imaging methods - and their concordance with histopathology.
PATIENTS AND METHODS: Two-hundred and ten patients (n = 210) participating in the POMB trial underwent pre-operative breast MRI at two Swedish breast units. Positive predictive values (PPV) for the incremental MRI findings were calculated for three subgroups of patients with: 1. alteration/alterations of treatment plan; 2. no alteration of treatment plan; and, 3. MRI-related conversion from BCS to mastectomy. Area under the receiver operating characteristic curve (AUC) was calculated using in-breast BI-RADS based ratings for the whole MRI group.
RESULTS: After exclusions a total number of 99 incremental findings in 78 patients were eligible for statistical analysis resulting in a PPV = 74%: (95% CI 60-84%) in 39 patients with MRI related alterations of initial treatment plans and 27%: (95% CI 14-44%) in 39 patients without. Positive predictive values of incremental findings decisive for specific treatment alteration/s were 83% (95% CI 68-92%) in patients with any alteration of initial treatment plans and 91% (95% CI 70-98%) for patients (n = 20/22) with conversion from breast conserving surgery to mastectomy. The empirical AUC for the incremental findings in the whole MRI group was 85% (95% CI 78-91%).
CONCLUSION: Breast MRI, performed and evaluated together with conventional breast imaging methods can provide relevant information at a high degree of accuracy in the pre-operative setting.
引用
- Karlsson A, Gonzalez V, Jaraj SJ, et al. The accuracy of incremental pre-operative breast MRI findings - Concordance with histopathology in the Swedish randomized multicenter POMB trial. Eur J Radiol. 2019. PMID: 31005171. doi:10.1016/j.ejrad.2019.03.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。